Insufficient scRNA-seq data for expression of NKRF at single-cell level.
Insufficient scRNA-seq data for expression of NKRF at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
bladder | 100% | 556.10 | 21 / 21 | 100% | 11.18 | 504 / 504 |
esophagus | 100% | 529.10 | 1445 / 1445 | 100% | 12.65 | 183 / 183 |
stomach | 100% | 423.38 | 359 / 359 | 100% | 11.48 | 286 / 286 |
uterus | 100% | 585.76 | 170 / 170 | 100% | 11.79 | 459 / 459 |
thymus | 100% | 592.62 | 653 / 653 | 100% | 9.31 | 604 / 605 |
brain | 100% | 1145.62 | 2637 / 2642 | 100% | 11.22 | 705 / 705 |
prostate | 100% | 591.91 | 245 / 245 | 100% | 8.92 | 501 / 502 |
ovary | 100% | 804.52 | 180 / 180 | 100% | 7.28 | 429 / 430 |
breast | 100% | 515.30 | 459 / 459 | 100% | 10.34 | 1115 / 1118 |
kidney | 100% | 539.21 | 89 / 89 | 100% | 7.02 | 898 / 901 |
lung | 100% | 610.37 | 576 / 578 | 100% | 10.42 | 1155 / 1155 |
intestine | 100% | 529.25 | 966 / 966 | 99% | 12.27 | 524 / 527 |
adrenal gland | 100% | 668.24 | 258 / 258 | 99% | 10.47 | 227 / 230 |
skin | 100% | 732.79 | 1809 / 1809 | 98% | 13.43 | 463 / 472 |
pancreas | 98% | 291.67 | 320 / 328 | 99% | 7.84 | 176 / 178 |
liver | 100% | 444.24 | 226 / 226 | 96% | 5.18 | 391 / 406 |
lymph node | 0% | 0 | 0 / 0 | 100% | 17.91 | 29 / 29 |
spleen | 100% | 887.64 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 10.22 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 6.91 | 1 / 1 |
adipose | 100% | 518.10 | 1203 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 599.67 | 1333 / 1335 | 0% | 0 | 0 / 0 |
muscle | 99% | 375.69 | 797 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 99% | 14.19 | 79 / 80 |
heart | 97% | 328.44 | 837 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 72% | 540.82 | 672 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0045892 | Biological process | negative regulation of DNA-templated transcription |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0005730 | Cellular component | nucleolus |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_0001228 | Molecular function | DNA-binding transcription activator activity, RNA polymerase II-specific |
GO_0005515 | Molecular function | protein binding |
GO_0001671 | Molecular function | ATPase activator activity |
GO_0003723 | Molecular function | RNA binding |
Gene name | NKRF |
Protein name | Truncated NF-kappaB repressing factor NF-kappaB repressing factor NFKB repressing factor NF-kappa-B-repressing factor (NFkB-repressing factor) (NRF) (Protein ITBA4) |
Synonyms | NRF hCG_23185 ITBA4 |
Description | FUNCTION: Enhances the ATPase activity of DHX15 by acting like a brace that tethers mobile sections of DHX15 together, stabilizing a functional conformation with high RNA affinity of DHX15 . Involved in the constitutive silencing of the interferon beta promoter, independently of the virus-induced signals, and in the inhibition of the basal and cytokine-induced iNOS promoter activity . Also involved in the regulation of IL-8 transcription . May also act as a DNA-binding transcription regulator: interacts with a specific negative regulatory element (NRE) 5'-AATTCCTCTGA-3' to mediate transcriptional repression of certain NK-kappa-B responsive genes . . |
Accessions | Q6NUN2 ENST00000688521.1 A2I830 ENST00000542113.3 [O15226-2] A1Z1A7 A2I827 A2I831 A2I832 A3F769 ENST00000304449.8 [O15226-1] A2I829 A2I828 A0A8I5KX72 O15226 |